ESTUTC-5 New YorkLog in Sign up

ACTU
Actuate Therapeutics, Inc. Common stock
stockNASDAQ

Market OpenNov 13, 2026 12:55:33 PM EST

0.30USD+1.284%(+0.00)96,543

Pre-marketNov 13, 2026 9:28:30 AM EST

0.3064USD+3.514%(+0.0104)

0.2500Bid0.3100Ask0.0700Spread

ACTU News

Day breaks

08:00 AM ESTActuate Therapeutics to Present Promising Preclinical Data Demonstrating Antitumor and Immune Activation Activity of Elraglusib Oral Tablet in Advanced Melanoma Models at ENA 2026 ·

GlobeNewswire Inc.

08:50 AM ESTActuate Therapeutics (ACTU) Secures USPTO Notice of Allowance for Oral Elraglusib Patent ·

GuruFocus

08:00 AM ESTActuate Therapeutics Receives U.S. Notice of Allowance for Patent Covering Elraglusib Oral Tablets ·

GlobeNewswire Inc.

01:31 AM ESTActuate Therapeutics CEO Daniel Schmitt purchases $49,999 in stock ·

Investing.com

08:18 AM EDTActuate Therapeutics prices $11M public offering of stock and warrants ·

Seeking Alpha

08:00 AM EDTActuate Therapeutics Announces Pricing of $11.0 Million Underwritten Public Offering ·

GlobeNewswire Inc.